These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7902663)

  • 1. IMOL 881, a new trypanocidal compound.
    Maes L; Songa EB; Hamers R
    Acta Trop; 1993 Sep; 54(3-4):261-9. PubMed ID: 7902663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro sensitivity of Trypanosoma evansi and T. equiperdum to diminazene, suramin, MelCy, quinapyramine and isometamidium.
    Zhang ZQ; Giroud C; Baltz T
    Acta Trop; 1991 Dec; 50(2):101-10. PubMed ID: 1685865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current therapy of trypanosomiasis].
    Doua F; Boa Yapo F
    Bull Soc Pathol Exot; 1994; 87(5):337-40. PubMed ID: 7496197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zoonotic trypanosomes in South East Asia: Attempts to control Trypanosoma lewisi using veterinary drugs.
    Desquesnes M; Yangtara S; Kunphukhieo P; Chalermwong P; Jittapalapong S; Herder S
    Exp Parasitol; 2016 Jun; 165():35-42. PubMed ID: 26988923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spiroarsoranes of second generation: evaluation of trypanocidal properties against Trypanosoma brucei brucei.
    Loiseau PM; Wolf JG; Gayral P
    Trop Med Parasitol; 1993 Mar; 44(1):32-6. PubMed ID: 8516630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an arsenical compound (RM 110, mel Cy, Cymelarsan) against susceptible and drug-resistant Trypanosoma brucei brucei and T.b. evansi.
    Zweygarth E; Kaminsky R
    Trop Med Parasitol; 1990 Jun; 41(2):208-12. PubMed ID: 2382101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of N,N'-dialkylbenzamide groups to trypanocidal properties of spiroarsoranes.
    Loiseau PM; Bories C; Trabelsi M; Gayral P; Wolf JG
    Parasitol Res; 1994; 80(8):708-10. PubMed ID: 7886045
    [No Abstract]   [Full Text] [Related]  

  • 8. Ever-increasing complexities of diamidine and arsenical crossresistance in African trypanosomes.
    de Koning HP
    Trends Parasitol; 2008 Aug; 24(8):345-9. PubMed ID: 18599351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of spiroarsoranes on Trypanosoma brucei brucei and T. b. rhodesiense.
    Loiseau PM; Jennings FW; Lubert P; Wolf JG
    Parasitol Res; 1996; 82(5):477-80. PubMed ID: 8738290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of RM110, a novel trypanocide, in the treatment of Trypanosoma evansi infections in camels.
    Zelleke D; Kassa B; Abebe S
    Trop Anim Health Prod; 1989 Nov; 21(4):223-6. PubMed ID: 2617676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary observations on the efficacy of mel Cy (Cymelarsan) in domestic animals infected with stocks of Trypanosoma brucei brucei and T.b. evansi.
    Zweygarth E; Ngeranwa J; Kaminsky R
    Trop Med Parasitol; 1992 Dec; 43(4):226-8. PubMed ID: 1293725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the trypanocidal activity of methyltriazenes in an animal model by the addition of an amidino group.
    Buddhu S; Penketh PG; Divo AA; Shyam K; Patton CL; Sartorelli AC
    Acta Trop; 1991 Apr; 49(1):69-72. PubMed ID: 1678578
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimization of the pharmacokinetic properties of potent anti-trypanosomal triazine derivatives.
    Salado IG; Baán A; Verdeyen T; Matheeussen A; Caljon G; Van der Veken P; Kiekens F; Maes L; Augustyns K
    Eur J Med Chem; 2018 May; 151():18-26. PubMed ID: 29604541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current chemotherapy of human African trypanosomiasis.
    Docampo R; Moreno SN
    Parasitol Res; 2003 Jun; 90 Supp 1():S10-3. PubMed ID: 12811544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drugs and drug resistance in African trypanosomiasis.
    Delespaux V; de Koning HP
    Drug Resist Updat; 2007; 10(1-2):30-50. PubMed ID: 17409013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The story of CGP 40 215: studies on its efficacy and pharmacokinetics in African green monkey infected with Trypanosoma brucei rhodesiense.
    Brun R; Burri C; Gichuki CW
    Trop Med Int Health; 2001 May; 6(5):362-8. PubMed ID: 11348531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in jugular circulation of Trypanosoma congolense in infected calves caused by effective trypanocides.
    Kalu AU; Ayandele J; Aina A
    Vet Rec; 1983 Jan; 112(4):82. PubMed ID: 6681919
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the efficacy of melarsenoxyde cysteamine (Cymelarsan) in treatment of camels experimentally infected with Trypanosoma evansi using antigen trapping enzyme-linked immunosorbent assay.
    Nyang'ao JM; Olaho-Mukani W; Maribei JM; Omuse JK
    J Vet Pharmacol Ther; 1995 Dec; 18(6):468-70. PubMed ID: 8789702
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro and in vivo activities of trybizine hydrochloride against various pathogenic trypanosome species.
    Kaminsky R; Brun R
    Antimicrob Agents Chemother; 1998 Nov; 42(11):2858-62. PubMed ID: 9797216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Veterinary link to drug resistance in human African trypanosomiasis?
    Barrett MP
    Lancet; 2001 Aug; 358(9282):603-4. PubMed ID: 11530144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.